Evidence map›Paper›PMID 24388052›Full record

ArticleThe Kaohsiung journal of medical sciences2014

Pharmacological implications from the adhesion-induced signaling profiles in cultured human retinal pigment epithelial cells.

Wen-Chuan Wu, Yo-Chen Chang, Kwou-Yeung Wu, Su-Yueh Chen, Ming-Chu Hsieh, Meng-Hsien Wu, Horng-Jiun Wu, Wen-Sheng Wu, Ying-Hsien Kao

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Minireview: Fibronectin in retinal disease.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Wen-Chuan WuDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yo-Chen ChangDepartment of Ophthalmology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kwou-Yeung WuDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Su-Yueh ChenDepartment of Nursing, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
Ming-Chu HsiehDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Meng-Hsien WuDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Horng-Jiun WuDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wen-Sheng WuDepartment of Laboratory Medicine and Biotechnology, College of Medicine, Tzu-Chi University, Hualien, Taiwan.
Ying-Hsien KaoDepartment of Medical Research, E-Da Hospital, Kaohsiung, Taiwan. Electronic address: danyhkao@gmail.com.
Kaohsiung Medical University Chung-Ho Memorial Hospital · TWKaohsiung Medical University · TWE-Da Hospital · TWTzu Chi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix (ECM) plays an active and complex role in regulating cellular behaviors, including proliferation and adhesion. This study aimed at delineating the adhesion-induced signaling profiles in cultured human retinal pigment epithelium (RPE) cells and investigating the antiadhesion effect of antiproliferative drugs in this context. RPE R-50 cells grown on various ECM molecules, such as type I and IV collagens, fibronectin, and laminin, were used for adhesion assay and for examining the phosphorylation profiles of signaling mediators including Akt, extracellular signal-regulated kinase (ERK) 1/2, and integrin-linked kinase (ILK) using Western blotting. The cells receiving antiproliferative drug treatment at subtoxic doses were used to evaluate their antiadhesive and suppressive effects on kinase activities. ECM coating enhanced adhesion and spreading of RPE cells significantly. The cellular attachment onto ECM-coated surfaces differentially induced Akt, ERK1/2, and ILK phosphorylation, and concomitantly increased p53 phosphorylation and cyclin D1 expression, but decreased Bcl-2/Bax ratios. Treatment with antiproliferative agents, including 5-fluorouracil, mitomycin C, and daunomycin, at subtoxic doses suppressed the ability of RPE cells to adhere to ECM substratum significantly. This suppression was in part mediated through reduction of integrin β1 and β3 expressions and interfering Akt-ILK signaling activity. Mechanistically, blockade of PI3K/Akt signaling resulted in the suppressed adhesion of RPE cells to ECM. These findings support the hypothesis that, in addition to their antimitogenic effect, antiproliferative agents also exhibit suppressive effect on the adhesiveness of cultured RPE cells. Moreover, inhibitors of the PI3K/Akt signaling mediator can potentially be used as therapeutic agents for proliferative vitreoretinopathy.

Indexed as

Signal TransductionAdhesivenessApoptosisCell AdhesionCell CycleCells, CulturedCell ShapeDaunorubicinEpithelial CellsExtracellular MatrixExtracellular Signal-Regulated MAP KinasesFluorouracilHumansKineticsMitomycinPhosphatidylinositol 3-KinasesDaunorubicinExtracellular Signal-Regulated MAP KinasesFluorouracilMitomycinPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktScaffold Protein ILKAktExtracellular matrixFibronectinIntegrin-linked kinaseMitogen-activated protein kinases

Identifiers

PMID24388052
PMCPMC11916111
OpenAlexW2025384799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.